We are live on ! Find out more
PBMWW

Psyence Biomedical Warrant
PBMWW

28 hedge funds and large institutions have $75.6K invested in Psyence Biomedical Warrant in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

7% less funds holding

Funds holding: 30 → 28 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

85% less capital invested

Capital invested by funds: $514K → $75.6K (-$439K)

Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
3
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$57.8K
2
Goldman Sachs
Goldman Sachs
New York
+$11.1K
3
WAM
Wolverine Asset Management
Illinois
+$677

Top Sellers

Rank Fund Capital Flow
1
EFI
EHP Funds Inc
Canada
-$86.3K
2
MSU
Mizuho Securities USA
New York
-$4.47K
3
PC
Periscope Capital
Ontario, Canada
-$4.17K
4
SSA
Schonfeld Strategic Advisors
New York
-$1.7K

PBMWW Hedge Fund Activity: Q2 2024 in Review

28 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q2 2024, worth a combined $75.6K — down 85% from $514K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PBMWW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Cowen and Company, adding an estimated $57.8K. The largest seller was EHP Funds Inc, exiting entirely with an estimated $86.3K sold.

  • 28 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q2 2024, down from 30 in Q1 2024.
  • Funds reported $75.6K of Psyence Biomedical Warrant stock for Q2 2024, down 85% quarter-over-quarter.
  • 1 fund opened new Psyence Biomedical Warrant positions in Q2 2024 and 3 closed out, a net change of -2 holders.
  • The largest Psyence Biomedical Warrant buyer in Q2 2024 was Cowen and Company, an estimated $57.8K added.
  • The largest Psyence Biomedical Warrant seller in Q2 2024 was EHP Funds Inc, an estimated $86.3K sold.

Based on aggregated 13F filings for Q2 2024.